Dr. Stephen L Fedder, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 107 Green Ln, Suite 655, Haverford, PA 19041 Phone: 610-649-4416 Fax: 610-649-3655 |
News Archive
Celgene Corporation today announced that information was posted on the FDA Web site indicating that an Abbreviated New Drug Application (ANDA) has been received by the Office of Generic Drugs (OGD) containing a "Paragraph IV" patent certification, for REVLIMID (lenalidomide) 25 mg capsules. Celgene has not yet received the Paragraph IV notification letter identifying the filer.
Examples of how the politics of Medicare have picked up momentum since Rep. Paul Ryan, R-Wis., advanced his proposal to revamp the proposal can be seen in a range of developments — including a letter from Democratic lawmakers to President Barack Obama, comments for Health and Human Services Secretary Kathleen Sebelius and even a tightening special election for a New York congressional seat.
Delirium occurs in about one in five inpatients, but appears to be a low priority with hospital staff, research suggests.
The skin, the blood, and the lining of the gut-adult stem cells replenish them daily. But stem cells really show off their healing powers in planarians, humble flatworms fabled for their ability to rebuild any missing body part. Just how adult stem cells build the right tissues at the right times and places has remained largely unanswered.
The MEDICREA Group, a company that specializes in the development of personalized implants produced for a patient's specific need in the treatment of spinal pathologies, today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration for UNiD, the world's first patient-specific spinal osteosynthesis rod.
› Verified 3 days ago